Karyopharm Therapeutics (25K0) Revenue

1 Followers

Karyopharm Therapeutics Revenue

Karyopharm Therapeutics had a revenue of 33.43M in the quarter ending Jun 30, 2026, with -4.66%. This bring the company's revenue in the last twelve months to 146.62M, Increased -2.98%. In the fiscal year ending Dec 31, 2025, Karyopharm Therapeutics had annual revenue of 146.07M with 0.57% growth.

Revenue (ttm)

146.62M

Revenue Growth

-0.18%

P/S Ratio

0.23

Revenue/Employee

€640,645

Employees

228

Market Cap

€33.58M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	146.07M	830.00K	+0.57%
Dec 31, 2024	145.24M	-796.00K	-0.55%
Dec 31, 2023	146.03M	-11.04M	-7.03%
Dec 31, 2022	157.07M	-52.74M	-25.14%
Dec 31, 2021	209.82M	101.73M	+94.12%
Dec 31, 2020	108.08M	67.19M	+164.31%
Dec 31, 2019	40.89M	10.56M	+34.80%
Dec 31, 2018	30.34M	28.73M	+1,790.09%
Dec 31, 2017	1.60M	―	―